Molecular hybridization-driven FAK inhibitors: N-2,4-diarylaminopyrimidine-3-sulfamoyl-benzamide derivatives with improved antitumor potency
Lidong Gong(Peking University), Zhiqiang Lin(Peking University), Ridong Li(Peking University), Yuxin Yin(Peking University), Runtao Li(Zhengzhou University), Junjie Huang(Zhejiang Medicine (China)), Xianling Ning(Peking University), Jianan He(Zhejiang Medicine (China)), Zichao Liang(Peking University)
Cited by 3
Related Papers
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
|Cancer Research|2017|237
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis
|Nature Cell Biology|2015|230
Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity
|Journal of Controlled Release|2013|211
Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A
|Molecular Cell|2019|127
Advances in pH-responsive drug delivery systems
|OpenNano|2021|117